Immunogenomic classification of hepatocellular carcinoma patients for immune check-point inhibitors therapy: cui bono?

Gut. 2023 Jan;72(1):7-9. doi: 10.1136/gutjnl-2022-327132. Epub 2022 Apr 26.
No abstract available

Keywords: HEPATOCELLULAR CARCINOMA; IMMUNOLOGY IN HEPATOLOGY; IMMUNOTHERAPY.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Comment

MeSH terms

  • Carcinoma, Hepatocellular* / drug therapy
  • Carcinoma, Hepatocellular* / genetics
  • Humans
  • Immunotherapy
  • Liver Neoplasms* / drug therapy
  • Liver Neoplasms* / genetics